Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Acute Lymphoid Leukemia

phorbol 12,13-dibutyrate has been researched along with Acute Lymphoid Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcantara, O; Boldt, DH; Javors, M1
Carchman, RA; Dunn, NL; Massey, GV; McCrady, CW; Russell, EC1

Other Studies

2 other study(ies) available for phorbol 12,13-dibutyrate and Acute Lymphoid Leukemia

ArticleYear
Induction of protein kinase C mRNA in cultured lymphoblastoid T cells by iron-transferrin but not by soluble iron.
    Blood, 1991, Mar-15, Volume: 77, Issue:6

    Topics: Calcium; Cytosol; Gene Expression Regulation, Leukemic; Humans; Iron; Phorbol 12,13-Dibutyrate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase C; RNA, Messenger; T-Lymphocytes; Transcription, Genetic; Transferrin; Tritium; Tumor Cells, Cultured

1991
Induction of tumoricidal activity and alterations of growth by interleukin-2 and manipulation of protein kinase C and cytosolic calcium in childhood acute lymphocytic leukemia cells.
    Leukemia, 1989, Volume: 3, Issue:8

    Topics: Calcium; Child; Child, Preschool; Cytotoxicity, Immunologic; Ethers; Female; Humans; Infant; Interleukin-2; Ionomycin; Male; Phorbol 12,13-Dibutyrate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase C; Receptors, Interleukin-2; Recombinant Proteins

1989